Please ensure Javascript is enabled for purposes of website accessibility

Your Health, Our Commitment

2020 Ponce de Leon Blvd, Suite PH 1, Coral Gables, FL 33134

Pharmacy and Drug Information

 

Pharmacy Updates

08/2022 – Addition of TRIZIVIR 150-300 MG TABLET to the Formulary

06/2022 – Information on Biosimilars

Reference: Overview of Biosimilar Products 

For more information, visit:

03/01/2022 – Notice of Changes to the Formulary effective 4/01/2022.

12/2021 – 2022 Provider Information of Opioid Drug Management Program (DMP).

08/2021 – Notice of Changes to the Formulary.

01/2021 – 2021 Provider Notification of Opioid Drug Management Program.

12/2020 – Warning on Concurrent use of Opioids and Benzodiazepines.

11/2020 – 2021 Formulary Update.

08/2020 – MedWatch Safety Alert – FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing Opioids or Medicines to Treat Opioid Use Disorder.

02/2020 – Newsletter – Provider Formulary Updates.

11/2019 – 2020 Provider Notification of Opioid Drug Management Program (DMP).

11/2019 – HHS Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use.

07/2019 – Newsletter – Provider Formulary Updates.

12/2018 – 2019 Provider notification of Opioid Drug Management Program.

 

Provider Prevention of Unauthorized Prescribing

To learn more click below:

 

Influenza Season 2021-2022 Update

08/2021- Influenza Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2021-22 Summary.

 

Recalls and Drug Safety Communications

 

07/2022 – Drug Recall Notice Drug Recall Notice Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100) by Mylan

07/2022 – Drug Recall Notice CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor by Vi-Jon

06/2022 – Drug Recall Notice Milk of Magnesia 2400 mg/10 mL Oral Suspension, Milk of Magnesia 2400 mg/30 mL Oral Suspension, Magnesium Hydroxide 1200 mg/Aluminum Hydroxide 1200 mg/Simethicone 120 mg per 30 mL Oral Suspension, and Magnesium Hydroxide 2400 mg/Aluminum Hydroxide 2400 mg/Simethicone 240 mg per 30 mL Oral Suspension by Plastikon

06/2022 – Drug Withdrawal from Market Notice- Ukoniq 200 mg tablets

05/2022 – Drug Recall Notice Anagrelide Capsules, USP 0.5 mg by Teva

04/2022 – Drug Recall Notice Accupril 10mg, 20mg, 40 mg tabs by Pfizer

03/2022 – Drug Recall Notice Orphenadrine ER 100 mg tab by Sandoz Pharmaceuticals

01/2022 – Metformin 750 mg ER tab by Viona Pharmaceuticals

12/2021 – Enoxaparin Sodium 40mg/0.4 mL injection by Sandoz

11/2021 – Lupin Pharmaceuticals’ Irbesartan and Irbesartan-HCTZ tablets

11/2021 – Drug Recall Notice for one lot of GLUCAGON® Emergency Kit

10/2021 – Drug Recall Notice Chantix tablets- All lots.

09/2021 – FDA Drug Safety Communication: Xeljanz/Xeljanz XR (tofacitinib), Olumiant (baricitinib) and Rinvoq (upadacitinib).

08/2021 – Drug Recall Notice Chantix tablets.

07/2021 – Drug Recall Notice Metformin HCl Extended-Release Tablets, USP 750 mg.

05/2021 – Drug Recall Notice NP Thyroid tablets.

02/2021 FDA Drug Safety Communication: Xeljanz, Xeljanz XR.

02/2021 – Drug Recall Notice Enoxaparin Sodium Inj. by Apotex.

07/2020 – Drug Recall Notice Metformin Hydrochloride ER 500 mg and 1000 mg tablets by Lupin Pharmaceuticals.

07/2020 – Drug Recall Notice Granule Pharmaceuticals Metformin Hydrochloride ER 750 mg tablets.

06/2020 – Drug Recall Notice Teva Metformin Hydrochloride ER 500 mg and 750 mg tablets.

06/2020 – Drug Recall Notice Amneal Metformin Hydrochloride ER 500 mg and 750 mg tablets.

05/2020 – Drug Recall Notice NP Thyroid tablets.

04/2020 – Drug Recall Notice Tetracycline 250mg and 500mg capsules.

04/2020 – Drug Recall Notice ALL Ranitidine and ZANTAC products.

01/2020 – Drug Recall Notice Ranitidine 150mg and 300mg capsules (Appco)

01/2020 – FDA warns about serious breathing problems with gabapentin and pregabalin when used with CNS depressants in patients with lung problems.

01/2020 – Drug Recall Notice Aurobindo Mirtazapine 7.5 mg tablets lot #03119002A3

12/2019 – Drug Recall Notice Expansion Amneal Ranitidine 150mg and 300mg Tablets and 15mg/mL syrup

11/2019 – Drug Recall Notice Amneal Ranitidine 150mg and 300mg Tablets and 15mg/mL syrup

11/2019 – Drug Recall Notice Aurobindo Ranitidine 150mg and 300 mg capsules, 150mg tablets and 15mg/mL syrup WEB

11/2019 – Drug Recall Notice Novitium  Ranitidine 150 mg and 300 mg tablets

11/2019 – Drug Recall Notice Lannett  Ranitidine 15mg/mL syrup

10/2019 – Drug Recall Notice Mylan Alprazolam products

10/2019 – Drug Recall Notice Dr. Reddy’s Ranitidine products

10/2019 – Drug Recall Notice Sandoz Rantidine Capsules

10/2019 – FDA Drug Safety Communication – Zantac (Ranitidine)

09/2019 – Drug Recall Notice – NATPARA (Parathyroid Hormone) for Injection

09/2019 – FDA Drug Safety Communication: Xeljanz, Zeljanz XR

08/2019 – Over the Counter (OTC) recall of multiple Altaire Ophthalmic products at CVS

08/2019 – Drug Recall Notice Relpax 40 mg tablets

07/2019 – Drug Recall – Altaire Pharmaceuticals – Ophthalmics

05/2019 – Drug Recall Notice Losartan and Losartan HCTZ

05/2019 – Drug Recall Losartan

05/2019 – FDA Drug Safety Communication for Prescription Insomnia Medicines: New Boxed Warning – Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake

04/2019 – Drug Recall Notice – Losartan Legacy MFXR

04/2019 – Drug Recall Notice – Valsartan

04/2019 – Drug Recall Notice Losartan and Losartan HCTZ

04/2019 – Drug Recall Notice Losartan

04/2019 – Drug Recall Notice Losartan HCTZ

01/2019 – Drug News and Alerts/ Recall Notice for  Irbesartan and Irbesartan HCTZ Tablets.

01/2019 – Drug News and Alerts/Recall Notice for Losartan Potassium tablets.

 

 

 

 

H4140_PRWSNOTIF_C
Last Updated: 08/02/2022

>